PharmaShots | Incisive News in 3 Shots

Subscribe Now

olaparib

AstraZeneca and MSD's Lynparza (Olaparib) Receives the CHMP's Positive Opinion as 1L Maintenance Treatment for HRD-Positive Advanced Ovarian Cancer

AstraZeneca and MSD's Lynparza (Olaparib) Receives the CHMP's Positive Opinion as 1L Maintenance Treatment for HRD-Positive Advanc...

September 21, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us